Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
The covalent binding of the hepatocarcinogen aflatoxin B1 by rat liver microsomes to calf thymus DNA resulted in a binding level equal to one aflatoxin residue per 60 DNA nucleotides. An aflatoxin derivative-guanine adduct was efficiently liberated from DNA with formic acid. Analytical reversed-phase high-pressure liquid chromatography of the DNA hydrolysate revealed that approximately 90% of the carcinogen bound to DNA could be accounted for as a single component. Preparative high-pressure liquid chromatography was used to isolate sufficient quantities of the adduct for structural analysis from large quantities (340 mg) of DNA. A combination of spectral and chemical data indicates that the major product of the interaction of metabolically activated aflatoxin B1 and DNA is 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 with the guanine and hydroxyl functions possessing a trans configuration. The structural data support the hypothesis that the putative 2,3-oxide of aflatoxin B1 is quantitatively important as an intermediate in the binding of aflatoxin B1 to nucleic acids.
D000348:Aflatoxins / Q000378:metabolism*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004247:DNA / Q000378:metabolism*; D006147:Guanine / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism*; D051381:Rats; D013056:Spectrophotometry, Ultraviolet
D000348:Aflatoxins; D006147:Guanine; D004247:DNA
Biochem Biophys Res Commun. 1974 Oct 8;60(3):1036-43
4429559
Cancer Res. 1975 Feb;35(2):382-9
234034
Biochem Biophys Res Commun. 1973 Aug 21;53(4):1260-7
4748819
Chem Biol Interact. 1973 Feb;6(2):125-9
4698160
Biochem J. 1972 Feb;126(4):893-900
5073240
Cancer Res. 1970 Mar;30(3):559-76
4915745
Cancer Res. 1975 Dec;35(12):3811-23
1104159
J Am Chem Soc. 1976 Sep 1;98(18):5714-5
956574
Chem Biol Interact. 1975 Aug;11(2):121-31
1139740
Cancer Res. 1975 Mar;35(3):844-50
1116139
Nature. 1969 Jul 12;223(5202):206-7
5791738
Biochem Pharmacol. 1969 Jan;18(1):153-7
5769345
J Am Chem Soc. 1967 Dec 6;89(25):6745-53
6063661
J Org Chem. 1967 Aug;32(8):2641-2
6043948
J Am Chem Soc. 1967 May 24;89(11):2719-25
6043801
J Am Chem Soc. 1965 Feb 20;87:882-6
14284616
Chem Biol Interact. 1976 Oct 2;15(2):149-64
975399
Cancer Res. 1975 Mar;35(3):832-43
1116138
Science. 1976 Aug 13;193(4253):592-5
959820
Cancer Res. 1977 Jan;37(1):172-81
187331
Proc Natl Acad Sci U S A. 1976 Jul;73(7):2311-5
821053
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;82(1):37-64
4280214
Cancer Res. 1973 Aug;33(8):1937-44
4720802